perfosfamide has been researched along with Experimental Mammary Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, O; Hanatani, Y; Ishibiki, K; Kamataki, T; Kato, R; Kubota, T; Nakada, M; Tsuyuki, K | 1 |
| Kaddurah-Daouk, R; Kufe, DW; Liu, J; Menon, K; Northey, D; Teicher, BA | 1 |
| Graham, CH; Kapitain, SJ; Kerbel, RS; Kobayashi, H; Man, S; Stankiewicz, KS | 1 |
| Croix, BS; Graham, CH; Kapitain, S; Kerbel, RS; Rak, JW; Sheehan, C | 1 |
| Chen, G; Frei, E; Teicher, BA | 1 |
| Antman, KH; Eder, JP; Frei, E; Herman, TS; Holden, SA; Teicher, BA | 1 |
| Cathcart, KN; Cucchi, CA; Flatow, JL; Frei, E; Holden, SA; Korbut, TT; Teicher, BA | 1 |
7 other study(ies) available for perfosfamide and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Antitumor effect and metabolic activation of cyclophosphamide and 4-hydroperoxycyclophosphamide in the human breast carcinoma (MX-1)-nude mouse system.
Topics: Adult; Animals; Biotransformation; Cyclophosphamide; Cytochrome P-450 Enzyme System; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 1983 |
Cyclocreatine in cancer chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Carmustine; Cell Division; Cell Survival; Cisplatin; Creatinine; Cyclophosphamide; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Lung Neoplasms; Mammary Neoplasms, Experimental; Melphalan; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 1995 |
Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents.
Topics: Animals; Breast Neoplasms; Cisplatin; Cyclophosphamide; Drug Resistance; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Time Factors; Tumor Cells, Cultured | 1994 |
Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Adhesion; Cell Adhesion Molecules; Cell Cycle; Cell Survival; Cyclophosphamide; Drug Resistance, Neoplasm; Female; Flow Cytometry; Hyaluronoglucosaminidase; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Time Factors; Tumor Cells, Cultured | 1996 |
Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype.
Topics: 7-Alkoxycoumarin O-Dealkylase; Aldehyde Dehydrogenase; Animals; Antineoplastic Agents, Alkylating; Cisplatin; Cyclophosphamide; Cytochrome P-450 Enzyme System; Drug Resistance, Neoplasm; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Immunoblotting; Liver; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Tumor Cells, Cultured | 1998 |
Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cell Hypoxia; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Drug Combinations; Fluorocarbons; Half-Life; Humans; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Thiotepa; Tumor Cells, Cultured | 1990 |
Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Survival; Cyclophosphamide; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Thiotepa; Tumor Cells, Cultured | 1988 |